ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
94,509.26
9.85%
S&P 500
5,954.50
1.59%
Dow Jones
43,840.91
1.39%
US Dollar vs Yen
150.625
0.00%
Brent Oil
73.045
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) ニュース

FARN

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:FARN
日付受信時刻ニュースソース見出しコード企業名
2025/02/2821 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Annual General MeetingLSE:FARNFaron Pharmaceuticals Oy
2025/02/2716 : 30RNS Regulatory NewsFaron Pharmaceuticals Oy Positive EMA Opinion on Orphan Drug DesignationLSE:FARNFaron Pharmaceuticals Oy
2025/02/2716 : 15RNS Regulatory NewsFaron Pharmaceuticals Oy Annual Report 2024 publishedLSE:FARNFaron Pharmaceuticals Oy
2025/02/2716 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Financial Statement 1 January to 31 December 2024LSE:FARNFaron Pharmaceuticals Oy
2025/02/1919 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Financial Statement and Annual ReportLSE:FARNFaron Pharmaceuticals Oy
2025/02/1421 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2025/02/1116 : 30RNS Regulatory NewsFaron Pharmaceuticals Oy Change of BrokerLSE:FARNFaron Pharmaceuticals Oy
2025/02/0700 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2025/02/0620 : 41Alliance NewsAlliance NewsFaron Pharmaceuticals raises EUR12 million from oversubscribed placingLSE:FARNFaron Pharmaceuticals Oy
2025/02/0616 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Results of Oversubscribed PlacingLSE:FARNFaron Pharmaceuticals Oy
2025/02/0601 : 30RNS Regulatory NewsFaron Pharmaceuticals Oy Proposed Issue and PlacingLSE:FARNFaron Pharmaceuticals Oy
2025/01/3116 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Final Patient Identified for BEXMAB Phase II StudyLSE:FARNFaron Pharmaceuticals Oy
2024/12/1316 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Financial Calendar for 2025LSE:FARNFaron Pharmaceuticals Oy
2024/12/1023 : 31Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals shares up as presents data on BexmabLSE:FARNFaron Pharmaceuticals Oy
2024/12/1016 : 47PR Newswire (US)Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
2024/12/1016 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
2024/12/0217 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Interactions with UK Regulatory AuthoritiesLSE:FARNFaron Pharmaceuticals Oy
2024/11/2720 : 29Alliance NewsAlliance NewsFaron announces promising findings from blood cancer drug trialLSE:FARNFaron Pharmaceuticals Oy
2024/11/2716 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB TrialLSE:FARNFaron Pharmaceuticals Oy
2024/11/1116 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune DiseasesLSE:FARNFaron Pharmaceuticals Oy
2024/11/0516 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Shareholders’ Nomination BoardLSE:FARNFaron Pharmaceuticals Oy
2024/10/2215 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024LSE:FARNFaron Pharmaceuticals Oy
2024/10/0715 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron announces Capital Markets DayLSE:FARNFaron Pharmaceuticals Oy
2024/08/3015 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
2024/08/2719 : 08Alliance NewsAlliance NewsFaron Pharma shares surge as US FDA grants fast track designationLSE:FARNFaron Pharmaceuticals Oy
2024/08/2715 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
2024/08/2715 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy FDA Grants Fast Track Designation for BexmarilimabLSE:FARNFaron Pharmaceuticals Oy
2024/08/2015 : 00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
2024/08/1321 : 23Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals joins US grant for battlefield woundsLSE:FARNFaron Pharmaceuticals Oy
2024/08/1315 : 00RNS Non-RegulatoryFaron Pharmaceuticals Oy Traumakine Research Collaboration and DoD GrantLSE:FARNFaron Pharmaceuticals Oy
 Showing the most relevant articles for your search:LSE:FARN

最近閲覧した銘柄

NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
COIN
XRPUSD
Ripple
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
COIN
DOGEUSD
Dogecoin
CCOM
US100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す